IRB Amendments: When to File, What Triggers a New Review, and How to Avoid Delays

Your study got approved. The protocol is locked. Enrollment is underway. And then something changes: you need to add a study site, your co-investigator leaves, the sponsor wants a new secondary endpoint, or you realize the consent form needs updated language about a data sharing arrangement you didn't anticipate.

None of this means your study is in trouble. Research changes as it goes, and the IRB needs to know about changes that could affect participant safety or the risk-benefit calculus it originally signed off on. Getting amendments right, without unnecessary back-and-forth, is mostly about understanding what actually requires a filing and what doesn't.

What is an IRB amendment?

An amendment (sometimes called a "modification" or "protocol change request") is a formal submission asking your IRB to approve a change to an already-approved study. Under both the Common Rule (45 CFR 46.103(b)(4)) and FDA regulations (21 CFR 56.108(a)), IRBs must review and approve proposed changes before they're implemented. The board approved a specific version of your study. If you materially change it, they need to weigh in.

Changes that require an amendment

Not every edit to a study document triggers an amendment, but more things do than most people expect. The common ones:

• Protocol changes. Adding or removing study procedures, changing the study design, modifying endpoints, adjusting dosing.
• Consent form revisions. New risk information, changes to compensation, updated data sharing terms, revised descriptions of what participants will actually do.
• Study personnel changes. Adding or removing a PI or co-investigator, especially if it affects who is overseeing the study day-to-day.
• Participant population changes. Expanding or narrowing inclusion/exclusion criteria, adding a pediatric cohort, enrolling from a new vulnerable population.
• Recruitment changes. New methods, revised ads, additional recruitment sites, or a different approach to identifying potential participants.
• Data collection changes. Adding a survey instrument, switching from in-person to remote data collection, introducing a new data source.
• Adding a study site. Each new site may need its own review, or at minimum an amendment to the existing approval.

If you're unsure whether a specific change qualifies, ask yourself: would it alter what a participant experiences, what risks they face, or what they were told in the consent process? If yes, file the amendment. For background on what goes into an initial submission and the criteria IRBs use to approve studies, see our submission readiness checklist.

The one exception: immediate safety concerns

Both the Common Rule (45 CFR 46.108(a)(3)(iii)) and FDA regulations (21 CFR 56.108(a)(4)) allow investigators to implement changes immediately when necessary to eliminate an apparent immediate hazard to participants. You act first, notify the IRB afterward. This is a safety valve, not a loophole. It applies when someone could get hurt, not when a change would be convenient to make now.

Minor vs. major amendments

IRBs distinguish between minor and major amendments, and the distinction determines the review pathway.

Minor amendments, things like fixing a typo in a consent form or updating a co-investigator's contact information, can usually be reviewed through expedited procedures by the IRB chair or a designated reviewer.

Major amendments, changes that meaningfully affect participant risk or the informed consent process, may require full board review. Think: adding a new invasive procedure, expanding enrollment to a vulnerable population, or substantially changing the study's primary objective.

The line between minor and major isn't always obvious, and honestly, it doesn't need to be from your side. Submit the amendment and let the IRB route it to the right review level. That's their call, and trying to pre-classify it yourself doesn't save time if you get it wrong.

Changes that typically do NOT need an amendment

A few things usually fall below the amendment threshold:

• Typo fixes in internal study documents that participants never see
• Updating an administrative phone number or mailing address
• Changes to internal SOPs that don't affect the approved protocol or participant-facing materials
• Logistical adjustments that don't touch procedures, risks, or consent

Every IRB has its own policies here. When in doubt, ask. If you're working with Tempus IRBs you may make the four types of changes listed above without getting our formal review and roll those changes into the next amendment that does require our review. Make sure you use appropriate document version control and change logs.

Writing a clear amendment submission

Most amendment delays we see come from incomplete or unclear submissions. The fix is straightforward.

State what changed, and be specific. Don't write "protocol updated." Write "We are adding a 10-item depression screening questionnaire (PHQ-10) to the Week 4 study visit." The reviewer shouldn't have to guess what they're looking at.

Explain why. Even a sentence helps. "The DSMB recommended adding depression screening after three participants reported mood changes during the intervention period" gives the reviewer the context they need to evaluate the change quickly.

Include redline versions of every modified document. Clean copies alongside are fine, but the tracked-changes version is what the reviewer actually works from. Skipping this step is probably the most common reason amendments take longer than they should.

Finally, if enrolled participants need to be re-consented, say so explicitly and describe how you plan to handle it.

Avoiding delays

Beyond what's above, a few things that will keep your amendment from bouncing back:

• Batch non-urgent changes. If you have three minor changes that can wait, submit them together instead of filing three separate amendments over three weeks.
• Submit against the current approved version. Amendments that reference an outdated version of the protocol create confusion and usually get sent back.
• Don't implement before approval. Outside of the immediate safety exception, implementing a change before the IRB signs off is a protocol deviation. It creates more paperwork, not less.

Amendments at Tempus IRB

At Tempus IRB, reviews of each minor amendments is a flat $500 and we review them on the same timeline as everything else, typically within a business day. You submit with your tracked-changes documents per the instrucitons in your original protocol approval letter and we take it from there. All our pricing is posted on our pricing page. Not sure whether a change to your study requires an amendment? Email us and we'll help you figure it out.

This post is for informational purposes only and does not constitute legal advice.